Results 21 to 30 of about 6,399,825 (302)

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

open access: yesFrontiers in Immunology, 2018
Dendritic cell (DC) vaccination can be an effective post-remission therapy for acute myeloid leukemia (AML). Yet, current DC vaccines do not encompass the ideal stimulatory triggers for innate gamma delta (γδ) T cell anti-tumor activity. Promoting type 1
Heleen H. Van Acker   +10 more
doaj   +1 more source

Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination [PDF]

open access: yesThe International Journal of Biochemistry & Cell Biology, 2014
Cancer vaccines can induce robust activation of tumor-specific CD8(+) T cells that can destroy tumors. Understanding the mechanism by which cancer vaccines work is essential in designing next-generation vaccines with more potent therapeutic activity.
Yared, Hailemichael, Willem W, Overwijk
openaire   +2 more sources

Genomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae

open access: yesmBio, 2019
Streptococcus pseudopneumoniae is a close relative of the major human pathogen S. pneumoniae. It is increasingly associated with lower-respiratory-tract infections (LRTI) and a high prevalence of antimicrobial resistance (AMR). S.
Geneviève Garriss   +8 more
doaj   +1 more source

Allogeneic tumor cell vaccines [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2013
The high mortality rate associated with cancer and its resistance to conventional treatments such as radiation and chemotherapy has led to the investigation of a variety of anti-cancer immunotherapies. The development of novel immunotherapies has been bolstered by the discovery of tumor-associated antigens (TAAs), through gene sequencing and proteomics.
Sanjay, Srivatsan   +6 more
openaire   +2 more sources

Whole Tumor Cell Vaccines for Glioma Immunotherapy [PDF]

open access: yesImmunotherapy, 2016
High-grade glioma is associated with an extremely poor prognosis despite standard treatment with surgery, radiotherapy and chemotherapy. There is a pressing need to develop more effective treatments. Recent advances in immunotherapy for solid cancers have invigorated the search for an effective immunotherapy for glioma.
Cameron S, Field   +2 more
openaire   +2 more sources

Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background The capacity of cytomegalovirus (CMV) to elicit long-lasting strong T cell responses, and the ability to engineer the genome of this DNA virus positions CMV-based vaccine vectors highly suitable as a cancer vaccine platform.
Elham Beyranvand Nejad   +8 more
doaj   +1 more source

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

open access: yesiScience, 2023
Summary: Hepatocellular carcinoma (HCC) is a fatal malignant tumor, but effective clinical interventions are limited. PLGA/PEI-mediated DNA vaccine encoding the dual targets of high-mobility group box 1 (HMGB1) or GPC3 was developed for HCC treatment ...
Xiaoqing Shi   +8 more
doaj   +1 more source

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. [PDF]

open access: yesPLoS ONE, 2010
Studies of patients with paraneoplastic neurologic disorders (PND) have revealed that apoptotic tumor serves as a potential potent trigger for the initiation of naturally occurring tumor immunity.
Mayu O Frank   +10 more
doaj   +1 more source

CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma. [PDF]

open access: yes, 2012
The Salmonella type III secretion system (T3SS) efficiently translocates heterologous proteins into the cytosol of eukaryotic cells. This leads to an antigen-specific CD8 T-cell induction in mice orally immunized with recombinant Salmonella. Recently, we
Jellbauer, Stefan   +11 more
core   +2 more sources

PD-1 blockage combined with vaccine therapy can facilitate immune infiltration in tumor microenvironment of Lynch syndrome colon cancer

open access: yesFrontiers in Genetics, 2022
Background: Lynch syndrome is a genetic disease resulting from mismatch repair gene mutation. Vaccine therapy can enhance the immunogenicity of Lynch syndrome and improve the therapeutic efficacy of immunotherapy.
Kai Ye   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy